Advanced search
Publication Cover
Emerging Microbes & Infections Volume 12, 2023 - Issue 2
Submit an article Journal homepage
4,107
Views
6
CrossRef citations to date
0
Altmetric
Influenza infections

An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses

Feifei XiongShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5804-272XView further author information
ORCID Icon,
Chi ZhangShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-9188-6307View further author information
ORCID Icon,
Baoyuan ShangShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaView further author information
,
Mei ZhengShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaView further author information
,
Qi WangShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaView further author information
,
Yahong DingShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaView further author information
,
Jian LuoShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4685-9008View further author information
ORCID Icon &
Xiuling LiShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2256422 | Received 31 May 2023, Accepted 01 Sep 2023, Published online: 06 Sep 2023

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Flavio Cargnin Faccin & Daniel R. Perez. (2024) Pandemic preparedness through vaccine development for avian influenza viruses. Human Vaccines & Immunotherapeutics 20:1.
Read now

Articles from other publishers (5)

Liang Xu, Weigang Ren, Qin Wang & Junwei Li. (2024) Advances in Nucleic Acid Universal Influenza Vaccines. Vaccines 12:6, pages 664.
Crossref
Amerah Parveen & Amal Ali Elkordy. (2024) Brief Insights into mRNA Vaccines: Their Successful Production and Nanoformulation for Effective Response against COVID-19 and Their Potential Success for Influenza A and B. Pathogens 13:6, pages 500.
Crossref
Tim R. Mosmann, Andrew J. McMichael, Alexandre LeVert, John W. McCauley & Jeffrey W. Almond. (2024) Opportunities and challenges for T cell-based influenza vaccines. Nature Reviews Immunology.
Crossref
Josien Lanfermeijer, Koen van de Ven, Marion Hendriks, Harry van Dijken, Stefanie Lenz, Martijn Vos, José A. M. Borghans, Debbie van Baarle & Jørgen de Jonge. (2024) The Memory-CD8+-T-Cell Response to Conserved Influenza Virus Epitopes in Mice Is Not Influenced by Time Since Previous Infection. Vaccines 12:4, pages 419.
Crossref
Mingyang Li, Mengyuan Liu, Shaohui Song, Ruirui Zhao, Yun Xie, Jing Liu, Lilan Xu, Xuefeng Ma, Mingyu Song, Jian Zhou & Guoyang Liao. (2024) Influenza a Neuraminidase-Based Bivalent mRNA Vaccine Induces Th1-Type Immune Response and Provides Protective Effects in Mice. Vaccines 12:3, pages 300.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.